Annual CFO
-$7.86 M
+$616.30 K+7.27%
December 31, 2023
Summary
- As of February 7, 2025, QNRX annual cash flow from operations is -$7.86 million, with the most recent change of +$616.30 thousand (+7.27%) on December 31, 2023.
- During the last 3 years, QNRX annual CFO has fallen by -$6.53 million (-487.51%).
- QNRX annual CFO is now -505.47% below its all-time high of -$1.30 million, reached on December 31, 2019.
Performance
QNRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.18 M
-$172.20 K-8.58%
September 30, 2024
Summary
- As of February 7, 2025, QNRX quarterly cash flow from operations is -$2.18 million, with the most recent change of -$172.20 thousand (-8.58%) on September 30, 2024.
- Over the past year, QNRX quarterly CFO has dropped by -$744.90 thousand (-51.93%).
- QNRX quarterly CFO is now -426.78% below its all-time high of -$413.70 thousand, reached on March 1, 2021.
Performance
QNRX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$8.84 M
-$857.80 K-10.74%
September 30, 2024
Summary
- As of February 7, 2025, QNRX TTM cash flow from operations is -$8.84 million, with the most recent change of -$857.80 thousand (-10.74%) on September 30, 2024.
- Over the past year, QNRX TTM CFO has dropped by -$1.29 million (-17.11%).
- QNRX TTM CFO is now -2037.88% below its all-time high of -$413.70 thousand, reached on March 1, 2021.
Performance
QNRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
QNRX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.3% | -51.9% | -17.1% |
| 3 y3 years | -487.5% | -24.8% | -8.7% |
| 5 y5 years | -505.5% | -24.8% | -8.7% |
QNRX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.5% | +7.3% | -64.9% | +32.4% | -54.6% | +9.0% |
| 5 y | 5-year | -505.5% | +7.3% | -426.8% | +32.4% | -2037.9% | +9.0% |
| alltime | all time | -505.5% | +7.3% | -426.8% | +32.4% | -2037.9% | +9.0% |
Quoin Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.18 M(+8.6%) | -$8.84 M(+10.7%) |
| Jun 2024 | - | -$2.01 M(+39.9%) | -$7.99 M(+5.8%) |
| Mar 2024 | - | -$1.43 M(-55.5%) | -$7.55 M(-4.0%) |
| Dec 2023 | -$7.86 M(-7.3%) | -$3.22 M(+143.9%) | -$7.86 M(+19.5%) |
| Sep 2023 | - | -$1.32 M(-16.0%) | -$6.58 M(-12.9%) |
| Jun 2023 | - | -$1.57 M(-10.0%) | -$7.55 M(-7.1%) |
| Mar 2023 | - | -$1.75 M(-10.1%) | -$8.13 M(-4.1%) |
| Dec 2022 | -$8.48 M | -$1.94 M(-15.3%) | -$8.48 M(-12.7%) |
| Sep 2022 | - | -$2.29 M(+6.6%) | -$9.72 M(+16.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$2.15 M(+2.8%) | -$8.33 M(+12.6%) |
| Mar 2022 | - | -$2.09 M(-34.1%) | -$7.40 M(+29.4%) |
| Dec 2021 | -$5.72 M(+327.3%) | - | - |
| Dec 2021 | - | -$3.18 M(+250.3%) | -$5.72 M(+125.1%) |
| Sep 2021 | - | -$907.50 K(-25.6%) | -$2.54 M(+55.5%) |
| Jun 2021 | - | -$1.22 M(+194.9%) | -$1.63 M(+294.9%) |
| Mar 2021 | - | -$413.70 K | -$413.70 K |
| Dec 2020 | -$1.34 M(+3.1%) | - | - |
| Dec 2019 | -$1.30 M | - | - |
FAQ
- What is Quoin Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals annual CFO year-on-year change?
- What is Quoin Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals quarterly CFO year-on-year change?
- What is Quoin Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals TTM CFO year-on-year change?
What is Quoin Pharmaceuticals annual cash flow from operations?
The current annual CFO of QNRX is -$7.86 M
What is the all time high annual CFO for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high annual cash flow from operations is -$1.30 M
What is Quoin Pharmaceuticals annual CFO year-on-year change?
Over the past year, QNRX annual cash flow from operations has changed by +$616.30 K (+7.27%)
What is Quoin Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of QNRX is -$2.18 M
What is the all time high quarterly CFO for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high quarterly cash flow from operations is -$413.70 K
What is Quoin Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, QNRX quarterly cash flow from operations has changed by -$744.90 K (-51.93%)
What is Quoin Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of QNRX is -$8.84 M
What is the all time high TTM CFO for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high TTM cash flow from operations is -$413.70 K
What is Quoin Pharmaceuticals TTM CFO year-on-year change?
Over the past year, QNRX TTM cash flow from operations has changed by -$1.29 M (-17.11%)